Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 821403, 6 pages
http://dx.doi.org/10.1155/2013/821403
Clinical Study

Ketosis-Onset Diabetes and Ketosis-Prone Diabetes: Same or Not?

Endocrinology and Metabolism Department of the Second Hospital Affiliated to Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang Province 150086, China

Received 1 March 2013; Revised 3 April 2013; Accepted 3 April 2013

Academic Editor: Ilias Migdalis

Copyright © 2013 Beiyan Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. E. Winter, N. K. Maclaren, W. J. Riley, D. W. Clarke, M. S. Kappy, and R. P. Spillar, “Maturity-onset diabetes of youth in black Americans,” The New England Journal of Medicine, vol. 316, no. 6, pp. 285–291, 1987. View at Google Scholar
  2. M. Maldonado, C. S. Hampe, L. K. Gaur et al., “Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5090–5098, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Kitabchi, “Ketosis-prone diabetes—a new subgroup of patients with atypical type 1 and type 2 diabetes?” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5087–5089, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Maldonado, M. E. Otiniano, R. Lee, L. Rodriguez, and A. Balasubramanyam, “Characteristics of ketosis-prone diabetes in a multiethnic indigent community,” Ethnicity and Disease, vol. 14, no. 2, pp. 243–249, 2004. View at Google Scholar · View at Scopus
  5. T. Aizawa, Y. Funase, M. Katakura et al., “Ketosis-onset diabetes in young adults with subsequent non-insulin- dependency, a link between IDDM and NIDDM?” Diabetic Medicine, vol. 14, no. 11, pp. 989–991, 1997. View at Google Scholar · View at Scopus
  6. K. Tanaka, T. Moriya, A. Kanamori, and Y. Yajima, “Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients,” Diabetes Research and Clinical Practice, vol. 44, no. 2, pp. 137–146, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. R. Maldonado, M. E. Otiniano, F. Cheema, L. Rodriguez, and A. Balasubramanyam, “Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved β-cell function,” Diabetic Medicine, vol. 22, no. 12, pp. 1744–1750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. E. Otiniano, A. Balasubramanyam, and M. Maldonado, “Presence of the metabolic syndrome distinguishes patients with ketosis-prone diabetes who have a type 2 diabetic phenotype,” Journal of Diabetes and Its Complications, vol. 19, no. 6, pp. 313–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Takamura, Y. Nagai, M. Torita et al., “Ketosis-onset diabetes without islet-associated autoantibodies in a patient with MELAS,” Diabetes Care, vol. 23, no. 7, pp. 1018–1019, 2000. View at Google Scholar · View at Scopus
  10. M. . Katakura, T. Aizawa, M. Naka et al., “Long-term prognosis of islet cell antibody-negative ketosis-onset diabetes with subsequent non-insulin dependency,” Diabetes Care, vol. 22, no. 9, pp. 1584–1586, 1999. View at Google Scholar
  11. F. Harzallah, N. Ncibi, H. Alberti et al., “Clinical and metabolic characteristics of newly diagnosed diabetes patients: experience of a university hospital in Tunis,” Diabetes and Metabolism, vol. 32, no. 6, pp. 632–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Harzallah, A. B. Brahim, L. Laadhar et al., “Ketosis-onset diabetes in Tunisian adults: immunological markers and β-cell function,” Eastern Mediterranean Health Journal, vol. 16, no. 1, pp. 70–74, 2010. View at Google Scholar · View at Scopus
  13. A. Balasubramanyam, R. Nalini, C. S. Hampe, and M. Maldonado, “Syndromes of ketosis-prone diabetes mellitus,” Endocrine Reviews, vol. 29, no. 3, pp. 292–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. Louet, S. B. Smith, J. F. Gautier et al., “Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes,” Diabetes, Obesity and Metabolism, vol. 10, no. 10, pp. 912–920, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Banerji and S. Dham, “A comparison of classification schemes for ketosis-prone diabetes,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 7, pp. 506–507, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. E. Grubin, T. Daniels, B. Toivola et al., “A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM,” Diabetologia, vol. 37, no. 4, pp. 344–350, 1994. View at Google Scholar · View at Scopus
  17. A. Falorni, E. Ortqvist, B. Persson, and A. Lernmark, “Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands,” Journal of Immunological Methods, vol. 186, no. 1, pp. 89–99, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. C. S. Hampe, L. P. Hammerle, L. Bekris et al., “Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 12, pp. 4671–4679, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications—part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Google Scholar
  20. E. Sobngwi and J. F. Gautier, “Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification,” Diabetologia, vol. 45, no. 2, pp. 283–285, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. G. E. Umpierrez, D. Smiley, and A. E. Kitabchi, “Narrative review: ketosis-prone type 2 diabetes mellitus,” Annals of Internal Medicine, vol. 144, no. 5, pp. 350–357, 2006. View at Google Scholar · View at Scopus
  22. S. P. Choukem, E. Sobngwi, L. S. Fetita et al., “Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes,” Diabetes Care, vol. 31, no. 12, pp. 2332–2337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Imran and E. Ur, “Atypical ketosis-prone diabetes,” Canadian Family Physician, vol. 54, no. 11, pp. 1553–1554, 2008. View at Google Scholar · View at Scopus
  24. W. C. Haaland, D. I. Scaduto, M. R. Maldonado et al., “A-β- subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome,” Diabetes Care, vol. 32, no. 5, pp. 873–877, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Balasubramanyam, G. Garza, L. Rodriguez et al., “Accuracy and predictive value of classification schemes for ketosis-prone diabetes,” Diabetes Care, vol. 29, no. 12, pp. 2575–2579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. S. Hampe, R. Nalini, M. R. Maldonado et al., “Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with β-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 462–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. G. E. Umpierrez, D. Smiley, G. Robalino, L. Peng, A. R. Gosmanov, and A. E. Kitabchi, “Lack of lipotoxicity effect on β-cell dysfunction in ketosis-prone type 2 diabetes,” Diabetes Care, vol. 33, no. 3, pp. 626–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Mauvais-Jarvis, E. Sobngwi, R. Porcher et al., “Ketosis-prone type 2 diabetes in patients of sub-saharan African origin: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance,” Diabetes, vol. 53, no. 3, pp. 645–653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Sobngwi, F. Mauvais-Jarvis, P. Vexiau, J. C. Mbanya, and J. F. Gautier, “Diabetes in Africans—part 2: ketosis-prone atypical diabetes mellitus,” Diabetes and Metabolism, vol. 28, no. 1, pp. 5–12, 2002. View at Google Scholar · View at Scopus
  30. T. Aizawa, M. Katakura, N. Taguchi et al., “Ketoacidosis-onset noninsulin dependent diabetes in Japanese subjects,” The American Journal of the Medical Sciences, vol. 310, no. 5, pp. 198–201, 1995. View at Google Scholar · View at Scopus
  31. G. E. Umpierrez, “Ketosis-prone type 2 diabetes: tme to revise the classification of diabetes,” Diabetes Care, vol. 29, no. 12, pp. 2755–2757, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Tuomi, L. C. Groop, P. Z. Zimmet, M. J. Rowley, W. Knowles, and I. R. Mackay, “Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease,” Diabetes, vol. 42, no. 2, pp. 359–362, 1993. View at Google Scholar · View at Scopus
  33. M. A. Ramos-Román, A. Piñero-Piloña, B. Adams-Huet, and P. Raskin, “Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration,” Journal of Diabetes and Its Complications, vol. 20, no. 3, pp. 137–144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Nalini, L. K. Gaur, M. Maldonado et al., “HLA class II alleles specify phenotypes of ketosis-prone diabetes,” Diabetes Care, vol. 31, no. 6, pp. 1195–1200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Laadhar, F. Harzallah, M. Zitouni et al., “HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients,” Experimental Diabetes Research, vol. 2011, Article ID 964160, 6 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Nalini, K. Ozer, M. Maldonado et al., “Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of “A-β+” ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection,” Metabolism, vol. 59, no. 10, pp. 1448–1455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Maldonado, S. D'Amico, M. Otiniano, A. Balasubramanyam, L. Rodriguez, and E. Cuevas, “Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis,” Diabetes, Obesity and Metabolism, vol. 7, no. 3, pp. 282–289, 2005. View at Publisher · View at Google Scholar · View at Scopus